| 缩写名/全名 | 
                                 
                                    BREAST CANCER RES TR
                                     
                            BREAST CANCER RESEARCH AND TREATMENT  | 
                        ||||||||||||||||||||
| ISSN号 | 0167-6806 | ||||||||||||||||||||
| 研究方向 | 医学-肿瘤学 | ||||||||||||||||||||
| 影响因子 | 2015:4.085, 2016:3.626, 2017:3.605, 2018:3.471, 2019:3.831, | ||||||||||||||||||||
| 出版国家 | UNITED STATES | ||||||||||||||||||||
| 出版周期 | Semimonthly | ||||||||||||||||||||
| 年文章数 | 437 | ||||||||||||||||||||
| 出版年份 | 1981 | ||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||
| 审稿周期(仅供参考) | 平均1月 | 
                        ||||||||||||||||||||
| 录用比例 | 约25% | ||||||||||||||||||||
| 投稿链接 | https://www.editorialmanager.com/brea/default.aspx | ||||||||||||||||||||
| 投稿官网 | http://link.springer.com/journal/10549 | ||||||||||||||||||||
| h-index | 139 | ||||||||||||||||||||
| CiteScore | 
                                
  | 
                        ||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0167-6806%5BISSN%5D | ||||||||||||||||||||
| 中科院SCI期刊分区 ( 2018年新版本)  | 
                            
                                
  | 
                        ||||||||||||||||||||
| 中科院SCI期刊分区 ( 2020年新版本)  | 
                            
                                
  | 
                        
| 中国学者近期发表的论文 | |
| 1. | Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with <Emphasis Type="Italic">BRCA1</Emphasis> and <Emphasis Type="Italic">BRCA2</Emphasis> mutation in China Author: Wei Cao, Yuntao Xie, Yingjian He, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Tao Ouyang Journal: BREAST CANCER RESEARCH AND TREATMENT, 2019, Vol., , DOI:10.1007/s10549-019-05199-8 DOI  | 
| 2. | Integrating of genomic and transcriptomic profiles for the prognostic assessment of breast cancer Author: Chengxiao Yu, Na Qin, Zhening Pu, Ci Song, Cheng Wang, Jiaping Chen, Juncheng Dai, Hongxia Ma, Tao Jiang, Yue Jiang Journal: BREAST CANCER RESEARCH AND TREATMENT, 2019, Vol., , DOI:10.1007/s10549-019-05177-0 DOI  | 
| 3. | Revealing clonality and subclonality of driver genes for clinical survival benefits in breast cancer Author: Yujia Lan, Erjie Zhao, Shangyi Luo, Yun Xiao, Xia Li, Shujun Cheng Journal: BREAST CANCER RESEARCH AND TREATMENT, 2019, Vol., , DOI:10.1007/s10549-019-05153-8 DOI  | 
| 4. | Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases Author: Zhi-Hua Liu, Kun Wang, Dan-Yi Lin, Jie Xu, Jie Chen, Xiao-Yu Long, Yan Ge, Xin-Lan Luo, Ke-Ping Zhang, Yan-Hui Liu, Fang-Ping Xu Journal: BREAST CANCER RESEARCH AND TREATMENT, 2019, Vol., , DOI:10.1007/s10549-019-05148-5 DOI  | 
| 5. | An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network Author: Min Sun, Di Wu, Ke Zhou, Heng Li, Xingrui Gong, Qiong Wei, Mengyu Du, Peijie Lei, Jin Zha, Hongrui Zhu, Xinsheng Gu, Dong Huang Journal: BREAST CANCER RESEARCH AND TREATMENT, 2019, Vol., , DOI:10.1007/s10549-019-05147-6 DOI  | 
| 6. | A high-risk luminal A dominant breast cancer subtype with increased mobility Author: Liping Guo, Guoji Chen, Wen Zhang, Lulin Zhou, Ting Xiao, Xuebing Di, Yipeng Wang, Lin Feng, Kaitai Zhang Journal: BREAST CANCER RESEARCH AND TREATMENT, 2019, Vol., , DOI:10.1007/s10549-019-05135-w DOI  | 
| 7. | ERα upregulates the expression of long non-coding RNA <Emphasis Type="Italic">LINC00472</Emphasis> which suppresses the phosphorylation of NF-κB in breast cancer Author: Zhanwei Wang, Dionyssios Katsaros, Nicoletta Biglia, Yi Shen, Lenora Loo, Xiao Yu, Hongyan Lin, Yuanyuan Fu, Wen-Ming Chu, Peiwen Fei, Yan Ni, Wei Jia, Xiaobei Deng, Biyun Qian, Herbert Yu Journal: BREAST CANCER RESEARCH AND TREATMENT, 2019, Vol., , DOI:10.1007/s10549-018-05108-5 DOI  | 
| 8. | Peer support interventions for breast cancer patients: a systematic review Author: Jieman Hu, Xue Wang, Shaoning Guo, Fangfang Chen, Yuan-yu Wu, Fu-jian Ji, Xuedong Fang Journal: BREAST CANCER RESEARCH AND TREATMENT, 2019, Vol., , DOI:10.1007/s10549-018-5033-2 DOI  | 
| 9. | Prevalence and characterization of <Emphasis Type="Italic">ATM</Emphasis> germline mutations in Chinese <Emphasis Type="Italic">BRCA1</Emphasis>/<Emphasis Type="Italic">2</Emphasis>-negative breast cancer patients Author: Ziguo Yang, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Juan Zhang, Yuntao Xie Journal: BREAST CANCER RESEARCH AND TREATMENT, 2019, Vol., , DOI:10.1007/s10549-018-05124-5 DOI  | 
| 10. | Combination of different types of elastography in downgrading ultrasound Breast Imaging-Reporting and Data System category 4a breast lesions Author: Xueyi Zheng, Yini Huang, Yun Wang, Yubo Liu, Fei Li, Jing Han, Jianwei Wang, Longhui Cao, Jianhua Zhou Journal: BREAST CANCER RESEARCH AND TREATMENT, 2018, Vol., , DOI:10.1007/s10549-018-05072-0 DOI  | 
  | 
  |